Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$71.72 - $91.47 $51.3 Million - $65.4 Million
-715,370 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $17.9 Million - $20.4 Million
-239,084 Reduced 25.05%
715,370 $55.3 Million
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $771,334 - $866,129
-10,215 Reduced 1.06%
954,454 $79.6 Million
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $4.5 Million - $5.47 Million
60,264 Added 6.66%
964,669 $72.8 Million
Q3 2020

Nov 16, 2020

BUY
$71.87 - $131.03 $65 Million - $119 Million
904,405 New
904,405 $68.8 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Davide Leone & Partners Investment CO Ltd. Portfolio

Follow Davide Leone & Partners Investment CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.